Aquestive Therapeutics targets $44M–$50M revenue in 2025 as Anaphylm launch preparations accelerate

Aquestive Therapeutics targets $44M–$50M revenue in 2025 as Anaphylm launch preparations accelerate

[og_img]

2025-05-13 15:36:29

Similar Posts